Department of Biology, Faculty of Medicine and Dentistry Palacky University, 775 15 Olomouc, Czech Republic.
Institute of Molecular Genetics of the Czech Academy of Sciences, 142 20 Prague, Czech Republic.
Int J Mol Sci. 2020 Dec 17;21(24):9652. doi: 10.3390/ijms21249652.
Molecular pathophysiology of Diamond-Blackfan anemia (DBA) involves disrupted erythroid-lineage proliferation, differentiation and apoptosis; with the activation of p53 considered as a key component. Recently, oxidative stress was proposed to play an important role in DBA pathophysiology as well. CRISPR/Cas9-created Rpl5- and Rps19-deficient murine erythroleukemia (MEL) cells and DBA patients' samples were used to evaluate proinflammatory cytokines, oxidative stress, DNA damage and DNA damage response. We demonstrated that the antioxidant defense capacity of Rp-mutant cells is insufficient to meet the greater reactive oxygen species (ROS) production which leads to oxidative DNA damage, cellular senescence and activation of DNA damage response signaling in the developing erythroblasts and altered characteristics of mature erythrocytes. We also showed that the disturbed balance between ROS formation and antioxidant defense is accompanied by the upregulation of proinflammatory cytokines. Finally, the alterations detected in the membrane of DBA erythrocytes may cause their enhanced recognition and destruction by reticuloendothelial macrophages, especially during infections. We propose that the extent of oxidative stress and the ability to activate antioxidant defense systems may contribute to high heterogeneity of clinical symptoms and response to therapy observed in DBA patients.
Diamond-Blackfan 贫血(DBA)的分子病理生理学涉及红系前体细胞增殖、分化和凋亡的紊乱;p53 的激活被认为是一个关键组成部分。最近,氧化应激也被认为在 DBA 病理生理学中起重要作用。CRISPR/Cas9 构建的 Rpl5 和 Rps19 缺陷型小鼠红白血病(MEL)细胞和 DBA 患者样本用于评估促炎细胞因子、氧化应激、DNA 损伤和 DNA 损伤反应。我们证明,Rp 突变细胞的抗氧化防御能力不足以满足更大的活性氧(ROS)产生,这导致氧化 DNA 损伤、细胞衰老和 DNA 损伤反应信号在发育中的红细胞中的激活以及成熟红细胞的特征改变。我们还表明,ROS 形成和抗氧化防御之间的失衡伴随着促炎细胞因子的上调。最后,DBA 红细胞膜的改变可能导致其被网状内皮巨噬细胞更易识别和破坏,尤其是在感染期间。我们提出,氧化应激的程度和激活抗氧化防御系统的能力可能导致 DBA 患者临床表现和治疗反应的高度异质性。